Ryan P. Blaney

Partner

Washington + 1.202.879.3414

Ryan Blaney advises clients on regulatory investigations, enforcement actions, litigations, cyber incidents, compliance, and corporate transactions in the areas of data privacy, cybersecurity, health care, and artificial intelligence (AI). He has two decades of experience representing health care entities, life sciences, private equity, financial services, retail companies, and technology firms.

Ryan has served as lead counsel defending clients in regulatory investigations conducted by agencies including HHS-OCR (U.S. Department of Health and Human Services Office for Civil Rights), DOJ (Department of Justice), FTC (Federal Trade Commission), FCC (Federal Communications Commission), and State Attorneys General and in quarterbacking responses to large-scale ransomware attacks and cyber breaches by nation-states. He also has substantial experience defending clients in False Claims Act litigations, obtaining several declinations and dismissals, and advising on DOJ's Civil Cyber-Fraud Initiative.

Ryan also has in-depth experience counseling clients on emerging AI, digital health, health care fraud and abuse, third-party reimbursement, and FDA (Food & Drug Administration) regulatory matters.

Before joining Jones Day, Ryan was a health care partner and chair of the Privacy & Cybersecurity practice at an AmLaw 50 firm. Prior to attending law school, Ryan earned a master’s degree in education and taught at an under-resourced Catholic middle school. Ryan has been repeatedly recognized for his public service and pro bono work. He has successfully handled numerous education-related cases, helped establish three nonprofit organizations, and defended qualified recipients of disability benefits.

Experiência

  • Riverside acquires ContruentJones Day represented The Riverside Company in the acquisition and financing of Contruent, an Illinois-based provider of lifecycle cost management software for owners of large capital assets and their contractors.
  • TriMas sells Aerospace segmentJones Day advised TriMas in the $1.45 billion sale of its Aerospace segment to an affiliate of Tinicum L.P.
  • Digital health start-up focused on high performance athlete care launches in U.S.Jones Day advised a digital health start-up focused on high performance athlete care launches in connection with its U.S. launch.